EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases

Sejal Kundra, Rupinder Kaur, Chirag Pasricha, Pratima Kumari, Thakur Gurjeet Singh, Ravinder Singh

International Immunopharmacology · 2024-09 · 139 · 112709

DOI: 10.1016/j.intimp.2024.112709 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Sejal Kundra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chitkara College of Pharmacy, Chitkara University, Punjab, India. Hauptthemen laut MEDLINE: Activins, Signal Transduction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 118 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activin A (Act A) is a member of the TGFβ (transforming growth factor β) superfamily. It communicates via the Suppressor of Mothers against Decapentaplegic Homolog (SMAD2/3) proteins which govern processes such as cell proliferation, wound healing, apoptosis, and metabolism. Act A produces its action by attaching to activin receptor type IIA (ActRIIA) or activin receptor type IIB (ActRIIB). Increasing circulating Act A increases ActRII signalling, which on phosphorylation initiates the ALK4 (activin receptor-like kinase 4) type 1 receptor which further turns on the SMAD pathway and hinders cell functioning. Once triggered, this route leads to gene transcription, differentiation, apoptosis, and extracellular matrix (ECM) formation. Act A also governs the immunological and inflammatory responses of the body, as well as cell death. Moreover, Act A levels have been observed to elevate in several disorders like renal fibrosis, CKD, asthma, NAFLD, cardiovascular diseases, cancer, inflammatory conditions etc. Here, we provide an update on the recent studies relevant to the role of Act A in the modulation of various pathological disorders, giving an overview of the biology of Act A and its signalling pathways, and discuss the possibility of incorporating activin-A targeting as a novel therapeutic approach for the control of various disorders. Pathways such as SMAD signaling, in which SMAD moves to the nucleus by making a complex and leads to tissue fibrosis in CKD, STAT3, which drives renal fibroblast activity and the production of ECM, Kidney injury molecule (KIM-1) in the synthesis, deposition of ECM proteins, SERCA2a (sarcoplasmic reticulum Ca2+ ATPase) in cardiac dysfunction, and NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) in inflammation are involved in Act A signaling, have also been discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ActivinsSignal TransductionHumansAnimalsNeoplasmsInflammation

Stichwörter der Autor:innen

Activin AChronic kidney diseaseInflammationSMAD signallingSTAT3TGFβ

Substanzen

Activinsactivin A

Autor:innen und Institutionen

  • Chitkara College of Pharmacy, Chitkara University, Punjab, India.
  • Chitkara College of Pharmacy, Chitkara University, Punjab, India. Electronic address: ravinder.singh@chitkara.edu.in.

Zitieren

APA

Kundra, S., Kaur, R., Pasricha, C., Kumari, P., Gurjeet Singh, T., & Singh, R. (2024). Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases. International Immunopharmacology, 139, 112709. https://doi.org/10.1016/j.intimp.2024.112709

Vancouver

Kundra S, Kaur R, Pasricha C, Kumari P, Gurjeet Singh T, Singh R. Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases. International Immunopharmacology. 2024;139:112709. doi:10.1016/j.intimp.2024.112709

BibTeX
@article{Kundra2024,
  author = {Kundra, Sejal and Kaur, Rupinder and Pasricha, Chirag and Kumari, Pratima and Gurjeet Singh, Thakur and Singh, Ravinder},
  title = {Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {139},
  pages = {112709},
  doi = {10.1016/j.intimp.2024.112709}
}
Kostenlos starten →